Report Detail
Global Antivirals Market Insights, Forecast to 2025
- RnM3442322 |
- 22 May, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global Antivirals market is valued at 46000 million US$ in 2018 and will reach 65400 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antivirals market based on company, product type, end user and key regions.
This report studies the global market size of Antivirals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antivirals in these regions.
This research report categorizes the global Antivirals market by top players/brands, region, type and end user. This report also studies the global Antivirals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s
Market size by Product
Generic
Branded
Market size by End User
Application I
HIV
Hepatitis
HSV
Influenza
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antivirals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antivirals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antivirals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antivirals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antivirals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antivirals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antivirals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antivirals Market Size Growth Rate by Product
- 1.4.2 Generic
- 1.4.3 Branded
- 1.5 Market by End User
- 1.5.1 Global Antivirals Market Size Growth Rate by End User
- 1.5.2 Application I
- 1.5.3 HIV
- 1.5.4 Hepatitis
- 1.5.5 HSV
- 1.5.6 Influenza
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antivirals Market Size
- 2.1.1 Global Antivirals Revenue 2014-2025
- 2.1.2 Global Antivirals Sales 2014-2025
- 2.2 Antivirals Growth Rate by Regions
- 2.2.1 Global Antivirals Sales by Regions
- 2.2.2 Global Antivirals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antivirals Sales by Manufacturers
- 3.1.1 Antivirals Sales by Manufacturers
- 3.1.2 Antivirals Sales Market Share by Manufacturers
- 3.1.3 Global Antivirals Market Concentration Ratio (CR5 and HHI)
- 3.2 Antivirals Revenue by Manufacturers
- 3.2.1 Antivirals Revenue by Manufacturers (2014-2019)
- 3.2.2 Antivirals Revenue Share by Manufacturers (2014-2019)
- 3.3 Antivirals Price by Manufacturers
- 3.4 Antivirals Manufacturing Base Distribution, Product Types
- 3.4.1 Antivirals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antivirals Product Type
- 3.4.3 Date of International Manufacturers Enter into Antivirals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antivirals Sales by Product
- 4.2 Global Antivirals Revenue by Product
- 4.3 Antivirals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antivirals Breakdown Data by End User
6 North America
- 6.1 North America Antivirals by Countries
- 6.1.1 North America Antivirals Sales by Countries
- 6.1.2 North America Antivirals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antivirals by Product
- 6.3 North America Antivirals by End User
7 Europe
- 7.1 Europe Antivirals by Countries
- 7.1.1 Europe Antivirals Sales by Countries
- 7.1.2 Europe Antivirals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antivirals by Product
- 7.3 Europe Antivirals by End User
8 Asia Pacific
- 8.1 Asia Pacific Antivirals by Countries
- 8.1.1 Asia Pacific Antivirals Sales by Countries
- 8.1.2 Asia Pacific Antivirals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antivirals by Product
- 8.3 Asia Pacific Antivirals by End User
9 Central & South America
- 9.1 Central & South America Antivirals by Countries
- 9.1.1 Central & South America Antivirals Sales by Countries
- 9.1.2 Central & South America Antivirals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antivirals by Product
- 9.3 Central & South America Antivirals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antivirals by Countries
- 10.1.1 Middle East and Africa Antivirals Sales by Countries
- 10.1.2 Middle East and Africa Antivirals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antivirals by Product
- 10.3 Middle East and Africa Antivirals by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Antivirals Products Offered
- 11.1.5 Merck Recent Development
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Johnson & Johnson Antivirals Products Offered
- 11.2.5 Johnson & Johnson Recent Development
- 11.3 Teva Pharmaceutical Industries
- 11.3.1 Teva Pharmaceutical Industries Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Pharmaceutical Industries Antivirals Products Offered
- 11.3.5 Teva Pharmaceutical Industries Recent Development
- 11.4 GSK
- 11.4.1 GSK Company Details
- 11.4.2 Company Business Overview
- 11.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 GSK Antivirals Products Offered
- 11.4.5 GSK Recent Development
- 11.5 Mylan
- 11.5.1 Mylan Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Mylan Antivirals Products Offered
- 11.5.5 Mylan Recent Development
- 11.6 Gilead Sciences
- 11.6.1 Gilead Sciences Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Gilead Sciences Antivirals Products Offered
- 11.6.5 Gilead Sciences Recent Development
- 11.7 F. Hoffmann-La Roche
- 11.7.1 F. Hoffmann-La Roche Company Details
- 11.7.2 Company Business Overview
- 11.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 F. Hoffmann-La Roche Antivirals Products Offered
- 11.7.5 F. Hoffmann-La Roche Recent Development
- 11.8 Bristol-Myers-Squibb
- 11.8.1 Bristol-Myers-Squibb Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bristol-Myers-Squibb Antivirals Products Offered
- 11.8.5 Bristol-Myers-Squibb Recent Development
- 11.9 AbbVie
- 11.9.1 AbbVie Company Details
- 11.9.2 Company Business Overview
- 11.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 AbbVie Antivirals Products Offered
- 11.9.5 AbbVie Recent Development
- 11.10 Aurobindo Pharma
- 11.10.1 Aurobindo Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Aurobindo Pharma Antivirals Products Offered
- 11.10.5 Aurobindo Pharma Recent Development
- 11.11 Cipla
- 11.12 Dr Reddy’s
12 Future Forecast
- 12.1 Antivirals Market Forecast by Regions
- 12.1.1 Global Antivirals Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antivirals Revenue Forecast by Regions 2019-2025
- 12.2 Antivirals Market Forecast by Product
- 12.2.1 Global Antivirals Sales Forecast by Product 2019-2025
- 12.2.2 Global Antivirals Revenue Forecast by Product 2019-2025
- 12.3 Antivirals Market Forecast by End User
- 12.4 North America Antivirals Forecast
- 12.5 Europe Antivirals Forecast
- 12.6 Asia Pacific Antivirals Forecast
- 12.7 Central & South America Antivirals Forecast
- 12.8 Middle East and Africa Antivirals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antivirals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antivirals. Industry analysis & Market Report on Antivirals is a syndicated market report, published as Global Antivirals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antivirals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
